XML 34 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
12. Segments, Products and Customers
9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Segments, Products and Customers

The Company manufactures probiotic, cultured, functional dairy health food products. The Company's primary product is kefir, a dairy beverage similar to but distinct from yogurt, in several flavors and in several package configurations. In addition to the drinkable products, Lifeway manufactures "Lifeway Farmer Cheese," a line of various farmer cheeses.

 

The Company has determined that it has one reportable segment based on how the Company's chief operating decision maker manages the business and in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing Company performance, has been identified collectively as the Chief Financial Officer, the Chief Operating Officer, the Chief Executive Officer and Chairperson of the board of directors.  Substantially all of the consolidated revenues of the Company relate to the sale of fermented dairy products which are produced using the same processes and materials and are sold to consumers through a network of distributors and retailers in the United States.

 

Net sales of products by category were as follows:

  

   Three months ended
September 30,
   Nine months ended
September 30,
 
   2017   2016   2017   2016 
Drinkable Kefir (a)  $25,134   $25,533   $80,382   $80,135 
Lifeway cheese products   2,561    2,479    7,750    7,579 
Pro Bugs Kefir products   819    1,606    3,586    4,962 
Frozen Kefir   272    372    918    1,015 
Net Sales  $28,786   $29,990   $92,636   $93,691 

 

(a) Excludes ProBugs Kefir products, and includes cream, cupped Kefir and cupped cheese products, supplements and other.

 

Significant Customers – Sales are predominately to companies in the retail food industry, located within the United States. Two major customers accounted for approximately 22% and 23% of net sales for the nine months ended September 30, 2017 and 2016, respectively, and 21% and 22% of net sales for the three months ended September 30, 2017 and 2016, respectively.